Bipolar Disorder in Children and Adolescents

CNS Spectrums

Volumn 8, Issue 12, 2003, Pages 954-959

  Wolf, Dwight V ^a   Wagner, Karen Dineen ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOTRANSFERASE; ANABOLIC AGENT; ANTICONVULSIVE AGENT; CANNABIS; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; COCAINE; GABAPENTIN; LAMOTRIGINE; LITHIUM CARBONATE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OPIATE; ORAL CONTRACEPTIVE AGENT; OXCARBAZEPINE; PLACEBO; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; TOPIRAMATE; TRANQUILIZER; UNCLASSIFIED DRUG; VALPROATE SEMISODIUM;

ACADEMIC ACHIEVEMENT; ACNE; AGRANULOCYTOSIS; ALOPECIA; APLASTIC ANEMIA; ATAXIA; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; BIPOLAR DISORDER; CATARACT; CHILD BEHAVIOR; CHILD HEALTH CARE; CLINICAL PROTOCOL; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; DIABETES INSIPIDUS; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIARRHEA; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG CHOICE; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG UTILIZATION; DYSPEPSIA; ELECTROCONVULSIVE THERAPY; ENURESIS; EXTRAPYRAMIDAL SYMPTOM; FAMILY; FATIGUE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GLAUCOMA; HEADACHE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; HUMAN RELATION; HYPERLIPIDEMIA; HYPERPHAGIA; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPONATREMIA; HYPOTHYROIDISM; INCREASED APPETITE; KIDNEY DYSFUNCTION; LEUKOCYTOSIS; LIVER FAILURE; LIVER TOXICITY; MYALGIA; NAUSEA AND VOMITING; NEPHROLITHIASIS; NERVOUSNESS; NEUROTOXICITY; NYSTAGMUS; ONSET AGE; OPEN STUDY; ORTHOSTATIC HYPOTENSION; OUTCOMES RESEARCH; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PARESTHESIA; PETIT MAL; POLYDIPSIA; POLYURIA; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RASH; RATING SCALE; RETROSPECTIVE STUDY; REVIEW; SEDATION; SIDE EFFECT; SOCIAL PSYCHOLOGY; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SYMPTOM; TACHYCARDIA; THIRST; THROMBOCYTOPENIA; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

EID: 1642601460     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900028728     Document Type: Review

References (40)

1. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;2:281-293.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press: 1994.
3. Geller B, Zimerman B, Williams M, et al. Diagnostic characteristics of 93 cases of prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol. 2000;10:157-164.
4. Carlson GA, Bromet EJ, Sievers S. Phenomenology and outcome of subjects with early- and adult-onset psychotic mania. Am J Psychiatry. 2000;157:213-219.
5. Geller B, Zimerman B, Williams M, et al. DSM-IV mania symptoms in a prepubertal and early adolescent bipolar disorder phenotype compared to attention-deficit hyperactive and normal controls. J Child Adolesc Psychopharmacol. 2002;12:11-25.
6. West SA, Strakowski SM, Sax KW, McElroy SL, Keck PE Jr, McConville BJ. Phenomenology and comorbidity of adolescents hospitalized for the treatment of acute mania. Biol Psychiatry. 1996;39:458-460.
7. Wozniak J, Biederman J, Mundy E, et al. A pilot family study of childhood-onset mania. J Am Acad Child Adolesc Psychiatry. 1995;34:1577-1583.
8. Kennah A, Birmaher B, Brent D, et al. Is bipolar disorder specifically associated with panic disorder in youth? Paper presented at: Annual Meeting of the American Academy of Child and Adolescent Psychiatry. October 24-29, 2000; New York, NY.
9. Kovacs M, Pollock M. Bipolar disorder and comorbid conduct disorder in childhood and adolescence. J Am Acad Child Adolesc Psychiatry. 1995;34:715-723.
10. Geller B, Zimerman B, Williams M, et al. Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry. 2001;158:125-127.
11. Geller B, Fox LW, Clark KA. Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry. 1994;33:461-468.
12. Strober M, Lampert C, Schmidt S, et al. The course of major depressive disorder in adolescents: 1. Recovery and risk of manic switching in a follow-up of psychotic and nonpsychotic subtypes. J Am Acad Child Adolesc Psychiatry. 1993;32:34-42.
13. Chang KD, Steiner H, Ketter TA. Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry. 2000;39:453-460.
14. Geller B, Craney JL, Bolhofner K, et al. Two-year prospective follow-up of children with a prepubertal and early adolescent bipolar disorder phenotype. Am J Psychiatry. 2002;159:927-933.
15. Strober M, Schmidtlackner S, Freeman R, et al. Recovery and Relapse in Adolescents with Bipolar Affective-Illness: a five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry. 1995;34:724-731.
16. Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorder during adolescence and young adulthood in a community sample. Bipolar Disord. 2000;2:281-293.
17. Wagner KD. Management of bipolar disorder in children and adolescents. Psychopharmacol Bull. 2002;36:151-159.
18. Geller B, Cooper TB, Sun K, et al. Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998;37:171-178.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. rev. Washington, DC: American Psychiatric Press; 1987.
20. Kafantaris V, Coletti DJ, Dicker R, et al. Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J Am Acad Child Adolesc Psychiatry. 2001;40:1448-56.
21. Hagino OR, Weller EB, Weller RA, et al. Untoward effects of lithium treatment in children aged four through six years. J Am Acad Child Adolesc Psychiatry. 1995;34:1584-1590.
22. Wagner KD, Weller E, Carlson G, et al. An open-label trial of divalproex in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2002;41:1224-1230.
23. Kowatch RA, Suppes T, Carmody TJ, et al. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry. 2000;39:713-720.
24. Kowatch RA, Carmody TJ, Suppes T, et al. Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders: a summary of two previous studies. Acta Neuropsychiatrica. 2000;12:145-149.
25. Isojarvi JI, Laatikainen TJ, Pakarinen AJ, et al. Poylcystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med. 1993;4;329:1383-1388.
26. Isojarvi JI, Laatikainen TJ, Knif M, et al. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol. 1996;39:579-584.
27. Rasgon NL, Altshuler LL, Gudeman D, et al. Medication status and polycystic ovary syndrome in women with bipolar disorder: a preliminary report. J Clin Psychiatry. 2000;61:173-178.
28. Kowatch RA, Carmody TJ, Suppes T, et al. Acute and continuation pharmacological treatment of children and adolescents with bipolar disorders: a summary of two previous studies. Acta Neuropsychiatrica 2000;12:145-149.
29. Davanzo PA, McCracken JT. Mood stabilizers in the treatment of juvenile bipolar disorder. Advances and controversies. Child Adolesc Psychiatr Clin N Am. 2000;9:159-182.
30. Frazier JA, Biederman J, Tohen M, et al. A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol. 2001;11:239-250.
31. Frazier JA, Meyer MC, Biederman J, et al. Risperidone treatment for juvenile bipolar disorder: a retrospective chart review. J Am Acad Child Adolesc Psychiatry. 1999;38:960-965.
32. Delbello MP, Schwiers ML, Rosenberg HL, et al. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry. 2002;41:1216-1223.
33. Ryback RS, Brodasky L, Munasifi F. Gabapentin in bipolar disorder. J Neuropsychiatry Clin Neurosci. 1997;9:301.
34. Delbello M, Kowatch RA, Warner J, et al. Topiramate use for pediatric bipolar disorder: a retrospective chart review. Poster session presented at: Annual Meeting of the Institute of Psychiatric Service; October 11, 2001; Orlando, FL.
35. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res. 1997;72:145-148.
36. Gilman JT. Lamotrigine: An antiepileptic agent for the treatment of partial seizures. Ann Pharmacother. 1995;29:144-151.
37. Reimherr JP, Rosen SJ, Leahy LF. Oxcarbazepine treatment in child and adolescent mood and anxiety disorders. Paper presented at: Annual Meeting of the United States Psychiatric Congress; October 28-31, 2002; Las Vegas, NV.
38. Masi G, Mucci M, Millepiede S. Clozapine in adolescent inpatients with acute mania. J Child Adolesc Psychopharmacol. 2002;12:93-99.
39. Rey JM, Walter G. Half a century of ECT use in young people. Am J Psychiatry. 1997;154:595-602.
40. Taieb O, Flament MF, Chevret S, et al. Clinical relevance of electroconvulsive therapy (ECT) in adolescents with severe mood disorder: evidence from a follow-up study. Eur Psychiatry. 2002;17:206-212.